Healthcare resource utilization and work loss in dermatomyositis and polymyositis patients in a privately-insured US population

Journal of Medical Economics, 2016 07; 19(7): 649-654

Dermatomyositis and polymyositis (DM/PM) are inflammatory myopathies characterized by muscle inflammation/weakness. Patients with DM/PM have a reduced quality-of-life and are at an increased risk for several comorbidities. Studies have assessed the incidence and prevalence of DM/PM; however, no study has estimated the burden of the diseases in terms of both healthcare resource utilization (HCRU) and work loss incurred by patients.

View abstract

Authors

Bradford Rice J, White A, Lopez A, Galebach P, Schepman P, Popelar B, Philbin M.